Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. - Wikidata - awgldk - TriplyDB

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

http://www.wikidata.org/entity/Q38212376

about

The search for novel analgesics: targets and mechanisms Managing Neuropathic Pain in Dogs Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex.Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine?Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors.The Effect of Sea Buckthorn ( L.) Seed Oil on UV-Induced Changes in Lipid Metabolism of Human Skin Cells

P2860

Q24288817-F2D02D56-1BEA-422B-A86B-081FCF29D4CF Q26768216-DA118D20-5431-41DC-9B08-1C82915AE78B Q36421863-46648007-3C0F-41FF-86A5-B0EF0F722736 Q36916261-93B78B26-94B2-4FF1-BD29-FC94BE801898 Q38694552-684D19C8-8287-4C8A-92B2-EB8EAFE8C996 Q42314593-0FEB87E0-D812-4691-9157-D8D4EDD04FFC Q42827034-FEBABA56-9892-44AC-B75A-FE1448276632 Q43075742-B8C0BE1B-C576-49F9-9115-8AFEAB818B28 Q46625215-22927A6C-3C58-43EA-90B5-EA68561A7DD4 Q53533652-F5DD8A48-E02A-4841-895B-223B779E038B Q55077096-0756130D-E157-4DE3-929C-BF9B7253A36F Q58710605-576A8249-899D-4C63-BED1-A35BF1859195

P2860

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

http://www.wikidata.org/entity/Q38212376

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

@en

type

label

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

@en

prefLabel

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

@en

P1433

Q38212376-44DBF10B-0337-4A33-872A-9391F395A8A8

P1476

Q38212376-D42D4F6D-6EA4-48BD-B3DA-97DF8B21A179

P2093

Q38212376-BACD045F-D7B1-4B93-B20A-DFF70A6DB428

P2860

Q38212376-02383E96-6913-4122-90E6-AC0BD74B3E86

Q38212376-02751F4A-CE48-4F20-9840-9D149B9823C0

Q38212376-028DAA61-2A1B-430B-BD0C-538415A5C28B

Q38212376-02CDF011-3B06-4EFA-A9CF-CB45DA1AB596

Q38212376-041AFCEE-7863-4155-B414-90450166FC8D

Q38212376-09E40019-F300-4A56-A2C8-44518016746E

Q38212376-0B6F6144-013B-4560-AF06-05A7872D212D

Q38212376-0DE0CA09-1266-4BB0-817A-CCF89EEAB5A3

Q38212376-12CAE9A5-2D28-4B0B-BE5B-21B2C3E7DD16

Q38212376-1313C5CE-BD9C-4CF0-B85A-E81A29E6B63B

P304

Q38212376-7A59064A-EC1D-4E22-8E63-A7C3384E8000

P31

Q38212376-BF3932FE-EC69-4E27-88F4-D9E3A1679EF2

P356

Q38212376-683635D3-5AE5-4018-8B05-BC354AB8B0AE

P407

Q38212376-1821C470-6653-4219-A857-FBEF76F225F5

P433

Q38212376-B9B80212-9E61-4CA6-A0F6-7725BF880B6E

P478

Q38212376-4FD96860-E83F-47DB-A6A2-5D21A192CA89

P577

Q38212376-698FDFB8-FE47-4DFA-88A7-A11759655753

P698

Q38212376-C95DB78F-777D-41BB-817B-C2D325CFE63F

P921

Q38212376-08EB9FF0-27A6-40C6-9A3E-CE417F7983D8

Q38212376-541e263e-addb-4ecc-9f4f-72eb688254d1

Q38212376-9FC2B40B-5F4D-480D-A475-C36EE959E117

Q38212376-B15FDDA4-5FB9-4B96-80BB-7E61CDA8DD2F

P356

13543784.2014.918603

P1433

Expert Opinion on Investigational Drugs

P1476

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

@en

P2093

Mellar P Davis

http://www.w3.org/2001/XMLSchema#string

P2860

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

The orphan receptor GPR55 is a novel cannabinoid receptor

P304

1123-1140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2014.918603

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24836296

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

pain management